Twitter Facebook RSS Feed Print
Your Baby

Babies Shouldn’t Be Given OTC Cold Medicines

2:00

When a baby is sick with a cold, the first reaction for many parents is to want to give their infant something to make him or her feel better. It’s a natural response; no parent likes to see their little one feeling bad. But turning to the medicine cabinet or making a trip to the pharmacy isn’t going to help your baby get better any quicker and could be dangerous says the U.S. Food and Drug Administration (FDA).

Over-the-counter (OTC) cold and cough medicine should not be given to children younger than 2 because they could cause serious and potentially deadly side effects, the agency warned.

Children often get more colds than adults, and parents might want to give them pain relievers, decongestants and other medicines, but that would be a mistake. The FDA says the best medicine is simple rest and care.

"A cold is self-limited, and patients will get better on their own in a week or two without any need for medications. For older children, some OTC medicines can help relieve the symptoms -- but won't change the natural course of the cold or make it go away faster," Dr. Amy Taylor, a medical officer in FDA's Division of Pediatric and Maternal Health, said in the news release.

A virus is what typically brings on a cold, but people often ask their physician or pediatrician (for their children) for antibiotics to treat them. Antibiotics are only useful for treating bacterial infections.

Colds are usually accompanied by coughing which can actually be useful to the body.

"Coughs help the body clear the mucus out of the airway and protect the lungs; so you don't want to suppress all coughs," Taylor said.

"Coughs help the body clear the mucus out of the airway and protect the lungs; so you don't want to suppress all coughs," she said.

Fever helps the body fight off an infection and does not always need to be treated. But if your child is uncomfortable because of fever or other symptoms of a cold, there are alternatives to cough and cold medicine to help them feel more comfortable. Taylor says they include the following actions:

·      Using a clean cool-mist vaporizer or humidifier in a small area near the child’s bed may help moisten the air and decrease the drying of the nasal passages and throat.

·      For infants with a stuffy nose, use saline or salt water drops/spray to moisten the nasal passages and loosen the mucus. Then clean the nose with a bulb syringe.

Non-drug treatments to ease coughs in children with colds include giving them plenty of fluids, especially warm drinks to soothe the throat.

While most children with colds do not need to see a doctor, Taylor said parents should call the doctor if they see any of these symptoms:

·      A fever in an infant aged 2 months or younger, or a fever of 102 Fahrenheit or higher at any age.

·       Signs of breathing problems, including nostrils widening with each breath, wheezing, fast breathing or the ribs showing with each breath.

·      Blue lips, ear pain, not eating or drinking, signs of dehydration.

·      Excessive crankiness or sleepiness, a cough that lasts for more than three weeks, or worsening condition.

·      A persistent cough may signal a more serious condition such as bronchitis or asthma.

"You have to know your child," Taylor said. "With small infants, fever is a major concern, and you need medical advice. If you are worried about your child's symptoms, at any age, call your pediatrician for advice."

The FDA voluntarily removed cough and cold products for children under two years old from the market because of on-going safety concerns discussed in 2007.  These safety concerns revealed that there were many reports of harm, and even death, to children who used these products.  These reports of harm occurred when the child received too medication such as in cases as accidental ingestion, unintentional overdose, or after a medication dosing error.  In those reports of harm that lead to a child’s death, most of those children were under two years of age.  

Since infant formulations of cough and cold products were voluntarily removed from the market years ago, parents who currently give these products to their infants (less than 2 years of age) may be using cough and cold products designed for older children and modifying the doses, for instance by giving half the recommended amount to the infant than what is recommended for an older child.  This can be especially dangerous as dosing adjustments cannot safely be made this way and could add to the existing risk of giving these products to young children.

Colds can be tough on children and adults and this is certainly the time of year when we all are more susceptible to getting one. Fluids and plenty of rest, plus sanitizing the area around the sick person and not sharing objects like silverware and drinking cups is the best treatment for colds. And of course the most important cold remedy for baby is mommy and daddy’s love and tender touch. 

Source: Robert Preidt, http://consumer.healthday.com/respiratory-and-allergy-information-2/common-cold-news-142/steer-clear-of-cold-meds-for-babies-fda-advises-693878.html

http://www.fda.gov/Drugs/ResourcesForYou/SpecialFeatures/ucm263948.htm

Your Baby

FDA Approves Newborn Screening Tests for 4 Rare Disorders

1:45

Depending on which state you live in, your newborn may be screened for a series of harmful or potentially fatal disorders when he or she is born.

With a simple blood test, doctors are often able to detect whether a newborn has certain unseen conditions that may cause problems later in life. Although these conditions are rare and most babies are given a clean bill of health, early diagnosis and proper treatment sometimes can make the difference between lifelong impairment and healthy development.

The U.S. Food and Drug Administration (FDA) recently permitted marketing of the “Seeker System,” for the screening of four rare inherited metabolic disorders. It is the first newborn screening test permitted for marketing by the FDA, for these disorders. The conditions are: Mucopolysaccharidosis Type 1 (MPS 1), Pompe, Gaucher and Fabry disease.

All of these disorders are inherited and involve deficiencies of different metabolic enzymes.  

The disorders occur in as few as 1 in 185,000 births, or as many as 1 in 1,500 births, depending on the disease, the agency said. The conditions collectively, are called Lysosomal Storage Disorders (LSDs), and can lead to organ damage and death if not treated in a timely way, the FDA added.

“The Secretary of HHS [U.S. Department of Health and Human Services] recently added Pompe and MPS I to the list of routine recommended newborn screening programs and it is anticipated that additional states will begin requiring use of screening tests to detect these disorders,” said Alberto Gutierrez, Ph.D., director of the Office of In Vitro Diagnostics and Radiological Health in the FDA’s Center for Devices and Radiological Health. “Accurate screening tests will help with early detection, treatment and control of these rare disorders in newborns, before permanent damage occurs. That’s why availability of LSD screening methods that have been assessed for accuracy and reliability by the FDA are so important.”

Some states now require screening of these disorders, the FDA said, including Arizona, Illinois, Kentucky, Michigan, Missouri, New Jersey, New Mexico, New York, Ohio, Pennsylvania and Tennessee.

The newly approved tests require blood samples collected from the prick of a newborn's heel within 48 hours of birth. The agency said it reviewed data from a clinical study of more than 154,000 infants in Missouri. The system identified at least one of the four disorders in 73 of the screened newborns, the agency said.

While some parents may be aware that they could be a carrier of a particular disease, many are not. Also, parents that have adopted an infant may not have a complete family medical history. Infant screenings can help bring parents peace of mind about their baby’s health or give them an early start on treatment for their child.

Story sources: HealthDay,  https://medicalxpress.com/news/2017-02-newborn-screening.html

http://kidshealth.org/en/parents/newborn-screening-tests.html

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm539893.htm

Your Baby

Recall: Britax B-Agile and BOB Motion Strollers

2:00

About 676,000 Britax B-Agile and BOB Motion Strollers with Click & Go receivers have been recalled. A damaged receiver mount on the stroller can cause the car seat to disengage and fall unexpectedly, posing a fall hazard to infants in the car seat.

Britax has received 33 reports of car seats unexpectedly disconnecting from the strollers and falling to the ground, resulting in 26 reports of injuries to children, including scratches, bruises, cuts and bumps to the head. In addition, Britax is aware of 1,337 reports of strollers with damaged Click & Go receiver mounts.

This recall involves Britax B-Agile and BOB Motion strollers (when used as a travel system with a car seat carrier attached). All models are folding, single or double occupant strollers and have Click & Go receiver mounts that attach the car seat carrier to the stroller frame. All colors of the stroller are included. The model number can be found on the inside of the stroller’s metal frame near the right rear wheel for single strollers and in the front middle underside of the frame on double strollers.

Consumers should immediately stop using their Click & Go receiver mounts and contact Britax for a free repair kit for single strollers.  Owners of the recalled double strollers should stop using them with car seats attached. Consumers can continue to use their stroller or car seat independently without the car seat attached to the stroller.

Consumers can contact Britax online at www.us.britax.com and click on the Safety Notice on the homepage or visit us.britax.com/recall, call toll-free at 844-227-0300 from 8:30 a.m.to 7 p.m. ET Monday through Friday and from 9 a.m. to 3 p.m. ET Saturday or email Britax at stroller.recall@britax.com.

Recalled models numbers include:

B-Agile:

S01298600, S01298700, S01635200, S02063600, S02063700, S02063800, S02063900, S02064000, S03803400, S03803500, S03803700, S03803800, S03803900, S04144400, S04144500, S04144600, S04144700, S04144800, S04144900, S04145000, S04183700, S04183800, S04184000, S04281200, S04281300, S04402800, S04437700, S04628500, S04884200, S04884300, S04884400, S04884500, S04975600, S04978900, S05060600, S05260200, S05511600, S05511700, S865800, S865900, S874300, S874400, S874500, S877200, S890100, S896000, S896200, S896600, S907200, S907300, S907400, S907500, S907600, S910200, S910300, S910400, S910500, S912300, S914300, S914500, S914700, S914900, S915200, S915400, S917400, S921800, S921900, S923700, U341763, U341764, U341782, U341783, U341825, U341826, U341828, U341X82, U34X782, U361763, U361818, U361819, U361825, U391875, U451835, U451837, U451841, U461763, U461764, U461782, U461783, U461825, U461826, U461828, U471818, U471819, U491842, U491843, U491844, U491908, U491909, U491910, U511875, U511877, U551835, U551837, U551841, U551861, U551862, U551863, U551864, U551865, U551905, U551906, U691878, U691879, U691881, U691882, U691884, U691904, U691905, U721895, U721896

BOB Motion:

S888600, S890200, S890300, S890400, S890500, S909700, S910600, S910700, S910800, S910900, S912600, U391820, U391821, U391822, U481820, U481821, U481822, U501820, U501821, U501822, U501907

Images of the strollers can be seen below.

Story Source: https://www.cpsc.gov/Recalls/2017/Britax-Recalls-Strollers

Your Baby

Recall: 2-in-1 Dream On Me Bassinet to Cradle

1:30

Dream on Me is recalling about 13,000 of their 2-in-1 Bassinet to Cradle products due to fall and suffocation hazards.

The wire supports on the sides of the bassinet can disconnect causing the fabric sides to lower; posing a risk that infants can fall out or become entrapped and suffocate.

This recall involves the 2-in-1 Bassinet to Cradle, sold in pink, blue, green, and white. The bassinet has metal frame supports and fabric sides with a removable half-canopy on the top.  The frame can also be adjusted with two rocking legs on each end of the bassinet.

It is designed with fabric handles and the option to remove the bassinet from the frame to use the bassinet portion as a “by the bed” sleeper product.

The recalled model numbers are:

·      439-A

·      439-B

·      439-G

·      439-P

·      439-W

The model numbers can be found on a tag that is located under the mattress pad of the bassinet. This tag is a removable tag you see in the store but is removed prior to use.

Dream on Me has received one incident of the wire frame support bracket failing and the fabric portion of the bassinet collapsing while an infant was asleep in the cradle.  No injuries have been reported.  

Consumers should immediately stop using the product and contact Dream On Me to obtain a free repair. In the meantime, parents are urged to find an alternate, safe sleeping environment for the child, such as a crib that meets current safety standards or play yard depending on the child’s age.

The recalled products were sold online at Amazon.com, Walmart.com, Wayfair.com, ToysRUs.com and Kohls.com from May 2012 to October 2014 for about $60.

Consumer can contact Dream on Me toll-free at (877) 201-4317, from 9 a.m. to 4:30 p.m. ET Monday through Friday, or online at www.dreamonme.com and click on the “Recalls” icon on the home page for more information.

Source: http://www.cpsc.gov/en/Recalls/2015/Dream-on-Me-Recalls-2-in-1-Bassinet-to-Cradle/#remedy

Your Baby

Special Baby Formulas Don’t Prevent Asthma, Allergies

2:00

Parents that have a baby at risk or allergies, asthma or type-1 Diabetes sometimes turn to hydrolyzed milk formulas in hopes of lowering their infant’s risk of developing these problems.

A new review of the data on hydrolyzed formulas finds that there is no evidence that they actually protect children from these types of autoimmune disorders.

"We found no consistent evidence to support a protective role for partially or extensively hydrolyzed formula," concluded a team led by Robert Boyle of Imperial College London in England.

"Our findings conflict with current international guidelines, in which hydrolyzed formula is widely recommended for young formula-fed infants with a family history of allergic disease," the study authors added.

In the study, Boyle's team looked at data from 37 studies that together included more than 19,000 participants and were conducted between 1946 and 2015.

The investigators found that infants who received hydrolyzed cow's milk formula did not have a lower risk of asthma, allergies (such as eczema, hay fever, food allergies) or type 1 diabetes compared to those who received human breast milk or a standard cow's milk formula.

The researchers also found no evidence to support an FDA-approved claim that a partially hydrolyzed formula could reduce the risk of the skin disorder eczema, or another conclusion that hydrolyzed formula could prevent an allergy to cow's milk.

Other experts in the United States said that the finding casts doubt on the usefulness of these kinds of specialized products.

"Allergies and autoimmune diseases [such as asthma, and type 1 diabetes] are on the rise and it would be nice if we did have a clear route to preventing them," said Dr. Ron Marino, associate chair of pediatrics at Winthrop-University Hospital in Mineola, N.Y.

"Unfortunately, despite U.S. Food and Drug Administration support [for hydrolyzed formula], the data are not compelling," he said.

Dr. Punita Ponda is assistant chief of allergy and immunology at Northwell Health in Great Neck, N.Y. She stressed that when it comes to infant feeding, breast milk is by far the healthiest option.

However, "current mainstream guidelines for infant formula do recommend that parents consider using hypoallergenic formula if a close family member -- like an older brother or sister -- has a food allergy," she said. That was based on prior studies supporting some kind of protective effect, Ponda said.

Protein hydrolysate formulas were first introduced in the 1940s for babies who could not tolerate the milk protein in cow’s milk.

Protein hydrolyzed formulas are formulas composed of proteins that are partially broken down or “hydrolyzed.” They are also called hydrolysates.

There are two broad categories of protein hydrolysates:

•       Partially hydrolyzed formulas (pHF)

•       Extensively hydrolyzed formulas (eHF)

Both partially and extensively hydrolyzed protein formulas are based on casein or whey, which are proteins found in milk.  

Hydrolyzed formulas have had the protein chains broken down into shorter and more easy-to -digest chains. The more extensively hydrolyzed the formula, the fewer potentially allergenic compounds remain.

Hydrolyzed formulas are also more expensive than regular cow’s milk formulas and often harder to find.

The researchers review was published March 08, 2016 in the BMJ.

Story sources: Robert Preidt, http://www.webmd.com/parenting/baby/news/20160308/special-infant-formulas-dont-shield-against-asthma-allergies-study

Victoria Groce, http://foodallergies.about.com/od/adultfoodallergies/p/hypoallergenic.htm

 

Your Baby

Fish Oil During Pregnancy May Reduce Baby’s Asthma Risk

2:00

A Danish study’s results suggests pregnant women that take a fish oil supplement during the final 3 months of pregnancy may reduce their baby’s risk of developing asthma or persistent wheezing.

The study involved 736 pregnant women, in their third trimester. Half the women took a placebo containing olive oil and the other group was given 2.4 grams of fish oil. The women took the supplements until one week after birth.

Among children whose mothers took fish-oil capsules, 16.9 percent had asthma by age 3, compared with 23.7 percent whose mothers were given placebos. The difference, nearly 7 percentage points, translates to a risk reduction of about 31 percent.

In the study, the researchers noted that they are not ready to recommend that pregnant women routinely take fish oil. Although the results of the study were positive, several experts have noted that more research needs to be done before higher doses of fish oil supplements are recommended over eating more fish.

Researchers found no adverse effects in the mothers or babies, the doses were high, 2.4 grams per day is 15 to 20 times what most Americans consume from foods.

One in five young children are affected by asthma and wheezing disorders. In recent decades, the rate has more than doubled in Western countries. Previous research has shown that those conditions are more prevalent among babies whose mothers have low levels of fish oil in their bodies. The new large-scale test, reported in The New England Journal of Medicine, is the first to see if supplements can actually lower the risk.

Before doctors can make any recommendations, the study should be replicated, and fish oil should be tested earlier in pregnancy and at different doses, Dr. Hans Bisgaard, the leading author of the study, said in an email to the New York Times. He is a professor of pediatrics at the University of Copenhagen and the head of research at the Copenhagen Prospective Studies on Asthma in Childhood, an independent research unit.

Dr. Bisgaard said it was not possible to tell from the study whether pregnant women could benefit from simply eating more fish. Pregnant women are generally advised to limit their consumption of certain types of fish like swordfish and tuna because they contain mercury. But many other types are considered safe, especially smaller fish like sardines that are not at the top of the food chain and therefore not likely to accumulate mercury and other contaminants from eating other fish.

“It is possible that a lower dose would have sufficed," the Bisgaard team said.

The supplements didn't seem to affect the odds of a baby or toddler developing the skin condition eczema, or an allergy such as a reaction to milk or egg products, or a severe asthma attack.

An editorial in the same journal by an expert who was not part of the study praised the research, saying it was well designed and carefully performed. The author of that editorial, Dr. Christopher E. Ramsden, from the National Institutes of Health, said the findings would help doctors develop a “precision medicine” approach in which fish-oil treatment could be tailored to women who are most likely to benefit.

If the findings are confirmed in other populations, doctors could test to see who would mostly likely benefit from fish oil supplements. "The health care system is currently not geared for such," Bisgaard said. "But clearly this would be the future."

If you are considering taking fish oil supplements during pregnancy, be sure and check with your OB/GYN for a recommended dose.

All fish oils are not the same. Some brands of fish oil are of higher quality than others. A reputable fish oil manufacturer should be able to provide documentation of third-party lab results that show the purity levels of their fish oil, down to the particles per trillion level. Also, if the supplements smell or taste fishy, they shouldn’t. High quality fish oil supplements don’t. Avoid fish oils that have really strong or artificial flavors added to them because they are most likely trying to hide the fishy flavor of rancid oil.

Story sources: Denise Grady, http://www.nytimes.com/2016/12/28/health/fish-oil-asthma-pregnancy.html?WT.mc_id=SmartBriefs-Newsletter&WT.mc_ev=click&ad-keywords=smartbriefsnl

Gene Emery, http://www.reuters.com/article/us-health-asthma-fish-oil-idUSKBN14H1T3

http://americanpregnancy.org/pregnancy-health/omega-3-fish-oil/

 

Your Baby

BPA Consumed During Pregnancy Linked to Obesity in Kids

1:45

Bisphenol A (BPA) is a chemical produced in large quantities and used primarily in polycarbonate plastics and epoxy resins.

You’ll find polycarbonate plastics in some plastic water bottles, food storage containers and plastic tableware. Epoxy resins are used in lacquers to coat metal products such as food cans, bottle tops, and water supply pipes.

The primary source of exposure to BPA for many people is through food and beverages.

Why should you be concerned about Bisphenol A?

BPA is thought to act as an endocrine disruptor--a compound that mimics or disrupts hormones produced by the human body. Previous research has linked BPA to asthma, ADHD, depression, anxiety and early puberty in girls. It has also been linked to diabetes, obesity and heart disease in adults.

A new study has also found a possible link between BPA and child obesity.

Researchers at Columbia University found that children of women exposed to BPA during pregnancy were likely to have more body fat by age seven. Increased body fat has been linked to a higher risk of obesity.

"This study provides evidence that prenatal exposure to BPA may contribute to developmental origins of obesity as determined by measures of body fat in children as opposed to the traditional indicator of body mass index, which only considers height and weight,” lead author of the study. Lori Hoepner, DrPH, said in a press release.

Dr. Hoepner and her colleagues studied 369 maternal-child pairs from pregnancy through early childhood.

The researchers collected urine samples during the last three months of pregnancy.

Urine samples were also collected from the children at ages three and five. The children's heights and weights were measured at age five and age seven.

At age seven the researchers also measured waist circumference and fat mass.

The researchers found 94 percent of the women had BPA in their urine--an indication that they had been exposed to the chemical.

Dr. Hoepner and colleagues found that children who had been exposed to BPA in the womb had a higher body fat mass. Even though the children might have been within the normal ranges for height and weight, they had a greater percentage of fat than would be normal at that age.

The researchers found a strong association between BPA, fat mass and waist circumference in girls. They also found that childhood exposure to BPA was not associated with fat mass, indicating that the prenatal exposure was the problem.

Some studies indicate that infants and children may be the most vulnerable to the effects of BPA. This new study also suggests that pregnant women might want to avoid BPA products.

The National Institute of Environmental Health Sciences offers these tips for reducing BPA exposure:

•       Don’t microwave polycarbonate plastic food containers. Polycarbonate is strong and durable, but over time it may break down from over use at high temperatures. Use glass or ceramics for microwaving foods.

•       Plastic containers have recycle codes on the bottom. Some, but not all, plastics that are marked with recycle codes 3 or 7 may be made with BPA.

•       Reduce your use of canned foods. Choose glass or other safe packaging or fresh or frozen foods when possible.

•       Opt for glass, porcelain or stainless steel containers, particularly for hot food or liquids.

•       Use baby bottles that are BPA free. 

The study was published in the May issue of Environmental Health Perspectives.

Story sources: Beth Greenwood, http://www.dailyrxnews.com/prenatal-exposure-bpa-was-associated-increased-fat-mass-children-columbia-university-study-found

http://www.niehs.nih.gov/health/topics/agents/sya-bpa/

 

Your Baby

FDA Recommends Limits on Arsenic in Rice Baby Food

1:45

The Food and Drug Administration (FDA) on Friday proposed new limits for inorganic arsenic in infant rice cereal, an effort to reduce the leading source of arsenic exposure for babies.

The draft guidance to industry would cap the inorganic arsenic at 100 parts per billion, a level that most infant rice cereals already meet, or are close to meeting, the agency said.

Arsenic is naturally present in water, air, food and soil in two forms: organic and inorganic. Organic arsenic passes through the body quickly and is less toxic. But inorganic arsenic may pose a cancer risk if consumed at high levels or over a long period of time. Rice is thought to have arsenic in higher levels than most other foods because it is grown in water on the ground, optimal conditions for the contaminant to be absorbed.

Babies' consumption of rice, which is primarily through rice cereal, is about three times greater than that of adults, according to the FDA. Most people consume the highest amount of rice, relative to their weights, at about 8 months of age.

The proposed limit is based on testing of rice and non-rice products, as well as a 2016 FDA risk assessment on the association between exposure to inorganic arsenic and adverse pregnancy outcomes and neurological effects in early life.

The agency said that inorganic arsenic exposure can result in a child's decreased performance on certain developmental tests.

The agency tested 76 samples of infant rice cereal from retail stores and found that nearly half met the agency's proposed limit of 100 parts per billion of inorganic arsenic. More than three-quarters of the samples had levels at or below 110 parts per billion.

The agency advised parents to feed their babies iron-fortified cereals; they can include oat, barley and other grains. It also urged pregnant women to consume a variety of foods, including grains, such as wheat, oats and barley. The FDA also noted that cooking rice in excess water - six to 10 parts water to one part rice - can reduce a significant part of the inorganic arsenic.

Urvashi Rangan, executive director of the Consumer Reports Food Safety & Sustainability Center, said that Consumer Reports was pleased by the FDA's proposal, which he said was close to the level proposed by the group three years ago. But he said the organization remains concerned that other rice-based products consumed by children and adults don't have any such standards. "This is particularly true of children's ready-to-eat cereals," he said, urging the FDA to set levels for these other products.

The agency will accept public comments on the proposed limits for 90 days.

Story source: Laurie McGinley, http://www.chicagotribune.com/lifestyles/health/ct-infant-rice-cereal-inorganic-arsenic-20160402-story.html

 

Your Baby

FDA Warning: No Homeopathic Teething Tablets or Gels

1:45

Some babies have little to no symptoms during teething, while others experience quite a bit of pain for months. When teething pain occurs, infants may cry and be irritable until they find relief.

Homeopathic tablets and gels aimed at helping soothe babies’ pain may be dangerous for infants and toddlers, the Food and Drug Administration (FDA) recently announced in a statement. 

The FDA is investigating reports of seizures in infants and small children who were given homeopathic teething products, which may contain "natural" compounds but are not regulated as drugs by the FDA.

In addition, the FDA said in the statement that "consumers should seek medical care immediately if their child experiences seizures, difficulty breathing, lethargy, excessive sleepiness, muscle weakness, skin flushing, constipation, difficulty urinating or agitation" after using homeopathic teething tablets and gels.

According to the National Center for Complimentary and Integrated Health, homeopathy relies on two theories: “like cures like”—the notion that a disease can be cured by a substance that produces similar symptoms in healthy people; and “law of minimum dose”—the notion that the lower the dose of the medication, the greater its effectiveness.

The FDA said in the statement that the agency is not aware of any proven health benefit of using homeopathic teething tablets and gels.

In 2010, the FDA issued a safety alert about a homeopathic teething tablet that contained belladonna. Belladonna — also called deadly nightshade — is a poisonous plant that contains a chemical called atropine. At high levels, atropine can be deadly. In homeopathy, it is used to treat redness and inflammation.

At the time, the FDA found that the teething tablets contained inconsistent amounts of belladonna. The company that made the tablets, Hyland, subsequently recalled the product.

Hyland issued a statement and video in response to the current FDA warning against the use of homeopathic teething remedies.

"As you may have seen, on September 30, 2016, the Food and Drug Administration issued a surprise statement recommending that consumers discontinue use of homeopathic teething tablets and gels because they may pose a risk," Hyland's stated. "We are fully cooperating with FDA’s inquiry and we’re providing them with all the data we have. We also hope to learn from FDA what facts, if any, the Agency has based its action on."

Hyland also noted “The safety and effectiveness of Hyland’s natural homeopathic medicines is our top priority. That’s why we work with regulators to ensure that our products meet the highest standards. If we ever had reason to be concerned of that safety, we would act immediately."

"Teething can be managed without prescription or over-the-counter remedies," Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, said in the FDA statement. 

The American Academy of Pediatrics (AAP) recommends teething rings or hard, unsweetened teething crackers. Do not use frozen teething toys because they can cause more discomfort by injuring a baby's mouth, the AAP advises.

Be sure and check with your pediatrician about teething pain relief if your little one is having a hard time getting through the teething process.

Story sources: Sara G. Miller, http://www.livescience.com/56352-fda-warning-homeopathic-teething-tablets.html

Michael Johnsen, http://www.drugstorenews.com/article/hylands-responds-fda-teething-tablet-warning

 

Pages

Please fill in your e-mail address to be included in our newsletter.
You may opt out at any time.

 

DR SUE'S DAILY DOSE

Can you use homeopathic products to relieve your child's illness?

DR SUE'S DAILY DOSE

Can you use homeopathic products to relieve your child's illness?

Please fill in your e-mail address to be included in our newsletter.
You may opt out at any time.

 

Please fill in your e-mail address to be included in our newsletter.
You may opt out at any time.